Olverembatinib T3071
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GZD824 is an orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT, IC50: 0.34 nM) and Bcr-Abl(T315I, IC50: 0.68 nM).
CAS nr:
1257628-77-5
Purity:
98%
Molecular Weight:
532,57
SMILES:
CN1CCN(Cc2c(cc(NC(=O)c3cc(C#Cc4cc5c([nH]nc5)nc4)c(C)cc3)cc2)C(F)(F)F)CC1
Formula:
C29H27F3N6O
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling
Target:
Bcr-Abl,Bcr-Abl,Bcr-Abl
